DOI:10.12289/j.issn.1008-0392.22487·临床研究·收稿日期:2022-12-13作者简介:马强(1989—),男,主治医师,博士.E-mail:mq_729@163.com通信作者:梁春立.E-mail:liang2006718@sina.com经胸锁乳突肌肌间入路行单侧甲状腺癌根治术的临床价值马强,步晓秋,沈雷,梁春立(同济大学附属东方医院甲状腺外科,上海200120)【摘要】目的探究经胸锁乳突肌肌间入路(sternocleidomastoidintermuscularapproach,SMIA)行单侧甲状腺癌根治术的可行性和安全性。方法回顾性分析2021年1月—2022年8月在同济大学附属东方医院收治的80例单侧甲状腺癌患者;其中观察组行SMIA手术(40例),对照组行经常规颈白线入路手术(40例)。比较两组患者基本情况、术中观察指标、术后恢复情况。结果两组患者在年龄、性别、癌灶直径、手术时间、术中出血量、中央组淋巴结清扫数目、术后甲状旁腺激素水平、术后引流量以及术后并发症方面差异均无统计学意义(P>0.05)。两组患者在切口隐蔽满意度、颈部麻木牵拉感、Vancouver瘢痕评定量表评分结果有明显差异(P<0.05)。结论与常规经颈白线入路相比,SMIA行单侧甲状腺癌根治术,在不影响手术效果的前提下,患者切口位置更加隐蔽、术后颈部麻木牵拉感更轻,切口更加美观,是安全可行、值得临床推广的一种手术方式。【关键词】经胸锁乳突肌肌间入路;经颈白线入路;单侧甲状腺癌根治术;临床应用【中图分类号】R736.1【文献标志码】A【文章编号】10080392(2023)05066605ThefeasibilityandsafetyofsternocleidomastoidintermuscularapproachinunilateralradicalthyroidectomyMAQiang,BUXiaoqiu,SHENLei,LIANGChunli(DepartmentofThyroidSurgery,ShanghaiEastHospital,SchoolofMedicine,TongjiUniversity,Shanghai200120,China)【Abstract】ObjectiveToevaluatetheefficacyandsafetyofsternocleidomastoidintermuscularapproach(SMIA)inunilateralradicalthyroidectomy.MethodsClinicaldataof80patientswhounderwentunilateralradicalthyroidectomyinEastHospital,TongjiUniversitySchoolofMedicinefromJanuary2021toAugust2022wereanalyzedretrospectively,including40caseswithSMIA(SMIAgroup)and40caseswithconventionallineaalbacervicalisapproach(controlgroup).Thebasicinformation,intraoperativeindicatorsandpostoperativeoutcomeswerecomparedbetweentwogroups.ResultsTherewasnosignificantdifferencesintheage,sex,tumorsize,operationtime,intraoper...
